Neurocrine Biosciences (NBIX)
(Delayed Data from NSDQ)
$136.70 USD
-2.96 (-2.12%)
Updated May 10, 2024 04:00 PM ET
After-Market: $136.38 -0.32 (-0.23%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/6/24 |
---|---|
Current Quarter | 1.04 |
EPS Last Quarter | 0.42 |
Last EPS Surprise | -59.62% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 4.17 |
Next Year | 6.51 |
EPS (TTM) | 3.63 |
P/E (F1) | 32.81 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 552.17M | 574.79M | 2.23B | 2.59B |
# of Estimates | 10 | 10 | 11 | 11 |
High Estimate | 581.00M | 619.00M | 2.36B | 2.87B |
Low Estimate | 539.50M | 554.70M | 2.18B | 2.40B |
Year ago Sales | 452.70M | 498.80M | 1.89B | 2.23B |
Year over Year Growth Est. | 21.97% | 15.23% | 18.33% | 15.93% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.04 | 1.29 | 4.17 | 6.51 |
# of Estimates | 11 | 9 | 10 | 11 |
Most Recent Consensus | 1.20 | 1.51 | 4.79 | 7.06 |
High Estimate | 1.62 | 1.51 | 5.51 | 8.52 |
Low Estimate | 0.27 | 1.15 | 3.10 | 4.81 |
Year ago EPS | 0.95 | 0.82 | 2.47 | 4.17 |
Year over Year Growth Est. | 9.47% | 57.32% | 68.83% | 56.29% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 5 | 0 | 7 |
Up Last 60 Days | 1 | 5 | 0 | 7 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 7 | 2 | 10 | 4 |
Down Last 60 Days | 7 | 1 | 10 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.04 | 1.29 | 4.17 | 6.51 |
7 Days Ago | 1.04 | 1.29 | 4.17 | 6.51 |
30 Days Ago | 1.16 | 1.27 | 4.83 | 6.23 |
60 Days Ago | 1.18 | 1.29 | 4.86 | 6.22 |
90 Days Ago | 1.18 | 1.29 | 4.95 | 6.25 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.04 | 1.30 | 4.17 | 6.51 |
Zacks Consensus Estimate | 1.04 | 1.29 | 4.17 | 6.51 |
Earnings ESP | 0.00% | 0.34% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.42 | 1.44 | 0.82 | 0.95 | NA |
Estimate | 1.04 | 1.13 | 0.91 | 0.77 | NA |
Difference | -0.62 | 0.31 | -0.09 | 0.18 | -0.06 |
Surprise | -59.62% | 27.43% | -9.89% | 23.38% | -4.68% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more